CTT Pharmaceutical Holdings, Inc. is a pharmaceutical technology company specializing in the development and commercialization of thin film oral drug delivery systems. The company utilizes a patented micelle-based thin film platform designed to provide rapid onset, enhanced patient convenience, and efficient absorption as an alternative to traditional dosage forms. Its business activities span pharmaceutical, therapeutic, and nutraceutical markets, with a specific focus on nicotine products and smoking cessation. CTT Pharmaceutical Holdings partners with academic institutions, including Johns Hopkins University, to conduct clinical trials and pursue regulatory preparedness. The company integrates scientific validation and scalable manufacturing to support product innovation and market entry in the United States.

Summarised from the company's own disclosures

Industry Biotechnology Homepage cttpharmaceuticals.com
Sector Healthcare IR page —
Tags
drug delivery, thin film technology, nicotine products, smoking cessation, oral dosage forms, micelle-based systems, Johns Hopkins University
Press page —

Metrics

Valuation  
Market cap $ 3.404M
P/E -0.48
P/BV 130.71
P/S —
P/OCF -47.12
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 38.8%
ROI 38.8%
ROIC -85.9%
Profit margin —
Growth  
Revenue growing —
Profits growing Yes
Revenue up 3y —
Revenue up 5y —
Quality  
Profitable Yes
Margin expanding —
Buying back stock No
Diluting (TTM) —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 10.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2004
Assets 1.662M 6.252K 203.079K 4.183M 1.262M 1.075M 1.549M 2.169M
Net profit 227.838K 110.464K -1.003M 3.739M -1.098M -1.629M — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

News

Ctt Pharmaceutical Holdings, Inc. — Other Events Bull 0 Bear 0 Routine

CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) : As previously reported on Form 8-K filed October 7, 2026, Holt & Patterson, our prior certifying public accountant resigned. Such firm confirmed that their resignation was not due to any disagreement on any matter related to our accounting practices or anything contained in a report issued by us. On October 27, 2026, CTT Pharmaceutical Holdings, Inc. signed an engagement letter with Zhanna Kelley, CPA as the Company’s PCAOB Auditor moving forward.

CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has parted ways with it’s auditor. There were no disagreements to accounting practices. The auditor is simply not handling SEC reporting companies moving forward. CTT Pharma will start looking for a new auditor and will reach out to another auditor the company has worked with before.

Prompts

Ctt Pharmaceutical Holdings, Inc. (ticker CTTH), listed in United States.

Company History

Date Change Detail
Oct 7, 2014 Renamed MINDESTA INC. → CTT PHARMACEUTICAL HOLDINGS, INC.
Aug 11, 2011 Renamed INDUSTRIAL MINERALS INC → MINDESTA INC.
May 31, 2002 Renamed PNW CAPITAL INC → INDUSTRIAL MINERALS INC